| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 09/21/2006 | CA2598865A1 Adenosine derivatives having a2a receptor activity |
| 09/20/2006 | EP1368364B1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/20/2006 | CN1835967A Viral polymerase and modulation thereof |
| 09/20/2006 | CN1275966C Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 09/19/2006 | US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 09/19/2006 | US7109316 New class of nucleoside triphosphates that contain an oligonucleotide of random or defined sequence attached to the base and are substrates for polymerases and terminal nucleotidyl transferases is described |
| 09/19/2006 | US7109314 Fluorescent nucleotides |
| 09/19/2006 | US7109312 Azo bonds attaching first, second and third alkoxy substituted radicals of aryls or heteraryls bound to a solid support through a linking group; can be incorporated into probes for detecting analytes rapidly, sensitively, reliably |
| 09/19/2006 | US7109183 Phosphohalohydrins, process for the production thereof and use thereof |
| 09/19/2006 | US7109181 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 09/19/2006 | US7109180 Stimulate mammalian coronary vasodilatation, imaging the heart |
| 09/19/2006 | US7107985 Pharmaceutical combination |
| 09/14/2006 | WO2006096757A2 Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens |
| 09/14/2006 | WO2006095831A1 Probe and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006095830A1 Linker compound, probe, and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006095740A1 Method for synthesizing nucleic acid by using substituted carbamoyl group as protecting group |
| 09/14/2006 | WO2006095739A1 Process for deblocking the 2'-hydroxyl groups of ribonucleosides |
| 09/14/2006 | WO2006066439A3 Rna-sequence or nucleoside/nucleotide analogues and method for producing the analogues |
| 09/14/2006 | WO2006065335A3 Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection |
| 09/14/2006 | WO2006007603A3 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 09/14/2006 | US20060205705 18,21-didehydro-18,21-dideoxo-18,21-dihydroxy-geldanamycin derivatives as anticarcinogenic agent; with a metal chelating agent |
| 09/14/2006 | US20060205687 Azacytosine analogs and derivatives |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205685 Alkyl, substituted or unsubstituted ribose, or 2'-deoxyribose substituted 1,3,5-triazin-2(1H)-ones, which may be additionally substituted with alkyl, aryl, halo, amino, oxy, thio, and/or hydrazine groups; used for treating diseases such as hematological disorders and cancer |
| 09/14/2006 | US20060205027 Forming of a biotinylated AGT binder-AGT complex, capturing and binding the complex with streptavidin conjugated to a peroxidase or a fluorophore, and removing unbound streptavidin; the amount of peroxidase or fluorophore bound to the complex indicates the level of AGT in the sample. |
| 09/13/2006 | EP1700922A2 Nitroindole derivatives and labeled oligonucleotide probes containing them |
| 09/13/2006 | EP1451365A4 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/13/2006 | EP1296997B1 Base analogues |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1272655B1 Stabilization of highly sensitive nucleic acid stains in aqueous solutions |
| 09/12/2006 | US7105661 producing nucleic acid (DNA or RNA) fragments enzymatically extended with morpholino-nucleoside triphosphates; dna polymerases |
| 09/12/2006 | US7105527 such as beta-D-N4-p-bromobenzoyl-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine; for treating human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections |
| 09/12/2006 | US7105499 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/12/2006 | US7105498 Increases bioavailability of uridine and cytidine; treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease; dosage forms |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105300 Comprises nucleotide analogs comprising phosphate carbamate groups; microfluidics |
| 09/09/2006 | WO2007144686A1 Nucleosides with non-natural bases as anti-viral agents |
| 09/09/2006 | CA2600359A1 Nucleosides with non-natural bases as anti-viral agents |
| 09/08/2006 | WO2006093987A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | WO2006093986A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/08/2006 | WO2006093157A1 Oligonucleotide derivative, probe for detection of gene, and dna chip |
| 09/08/2006 | WO2006093110A1 Nitroguanosine-3’,5’-cyclic monophosphate and protein kinase g activator |
| 09/08/2006 | WO2006092808A1 Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides |
| 09/08/2006 | WO2006066074A3 Lung-targeted drugs |
| 09/08/2006 | WO2003062255A3 Sugar modified nucleosides as viral replication inhibitors |
| 09/08/2006 | CA2819464A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/08/2006 | CA2598895A1 Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides |
| 09/08/2006 | CA2597685A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | CA2597683A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/08/2006 | CA2574088A1 Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/07/2006 | US20060199959 Process for preparing 2',3'-didehydro-2'3'-dideoxynucleosides and 2',3'-dideoxynucleosides |
| 09/07/2006 | US20060199953 Thionucleoside s-nitrosyl derivative |
| 09/07/2006 | US20060199783 Anti-Hepatitis c nucleosides containing 2-deoxy-2-fluoro-2-C-methyl- beta -D-ribofuranosyl nucleosides from a naturally-occurring nucleoside; Ethyl trans-2,3-dideoxy-4,5-O-isopropylidene-2-C-methyl-D-glycero-pent-2-enonate |
| 09/07/2006 | US20060199776 7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-2H -chromen-2-one, for example; neuroprotective agents |
| 09/07/2006 | US20060199768 Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens |
| 09/07/2006 | US20060199192 genetic probes modified at the 5' terminus by a functional group, which is linked to the nucleic acid through an activating leaving group and a tether, that provide for detectable or functional changes following their release from the modified nucleic acid; kits for detecting of nucleic acid sequences |
| 09/06/2006 | EP1698635A1 Benzimidazole derivatives and medical uses thereof |
| 09/06/2006 | EP1697394A2 Comt inhibitors |
| 09/06/2006 | EP1697393A1 Improved synthesis of 2-substituted adenosines |
| 09/06/2006 | CN1829729A 新颖化合物 Novel compounds |
| 09/06/2006 | CN1827633A Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
| 09/06/2006 | CN1827632A Process for purifying zidovudine palmitate raw materials and preparations thereof |
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273477C Selenium-containing tegafur sulfophosphatide conjugate on glycerin skeleton and its synthesis |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/05/2006 | US7101994 Process for preparing substituted benzimidazole compounds |
| 09/05/2006 | US7101993 Oligonucleotides containing 2′-O-modified purines |
| 09/05/2006 | US7101992 Nucleic acid base pair |
| 09/05/2006 | US7101986 Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
| 08/31/2006 | WO2006090029A1 Gemcitabine derivatives nanoparticles |
| 08/31/2006 | WO2006060614A9 Methods for preparing pimecrolimus |
| 08/31/2006 | WO2006033709A3 Novel nucleoside derivatives |
| 08/31/2006 | US20060194749 9-halo-2-(2'-methyl- beta -D-ribofuanosyl)-2,6-dihydro-2,3,5,6-tetraaza-benzo[cd]azulen-7-one; 9-Amino-2-(2'-methyl- beta -D-ribofuranosyl)-2,6-dihydro-2,3,5,6-tetraaza-benzo[cd]azulen-7-one; for treateing Flaviviridae family of virus infections ( hepatitis C virus) |
| 08/31/2006 | US20060194258 Polypeptide array synthesis |
| 08/30/2006 | EP1695979A2 Gapped 2' modified oligonucleotides |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1694691A1 Improved synthesis of 2-substituted adenosines |
| 08/30/2006 | EP1694642A2 Mutagenic heterocycles |
| 08/30/2006 | CN1826348A Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 08/30/2006 | CN1826347A Indolopyrrolocabazole derivative and antitumor agent |
| 08/30/2006 | CN1272299C Selective oxidation process with enhanced safety |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098286 Covalently attaching to the surface a functionalized silicon compound include at least one activated silicon group and at least one derivatizable functional group |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/24/2006 | US20060190186 Viral polymerase and modulation thereof |
| 08/24/2006 | US20060189800 Indolopyrrolocabazole derivative and antitumor agent |
| 08/24/2006 | US20060189555 Pyrroles substituted by oligonucleotides |
| 08/24/2006 | US20060188927 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA |
| 08/24/2006 | US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/24/2006 | US20060188901 labelling nucleotides using terminal transferases, polymerases or a reverse transcriptase; sequence determination |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | CN1823084A Methods for preparing 2-alkynyladenosine derivatives |
| 08/23/2006 | CN1821420A Method of preparing a guanosine-group compound and an intermediate thereof |
| 08/23/2006 | CN1271080C Process for preparing cytidine-S'-phosphate |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |